Newsroom

Your source for the latest news, insights and innovation updates shaping the animal health industry.

Featured News

Subscribe to The Connector

Get the latest animal health news in our monthly newsletter.

The Connector | April 2026

Your monthly source for Animal Health industry news.

FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs

Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK), today announced the U.S. Food and Drug Administration (FDA) approved an expanded label for BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) in dogs.

Animal Health Market Size is Poised to Reach USD 152.28 Billion by 2033 Owing to the Surging Demand for Production Animals to Meet Food Demand Globally

According to SNS Insider, The Animal Health Market Size was valued at USD 67.13 Billion in 2025E and is expected to reach USD 152.28 Billion by 2033 and grow at a CAGR of 10.79% over 2026-2033.

IPIFF and Argenta Join Forces to Accelerate Innovation in Insect-Based Animal Health and Nutrition Products and Human Nutrition products

The International Platform of Insects for Food and Feed (IPIFF) and Argenta, the world’s only global animal health and nutrition Contract Research and Development Organization (CRO/CDMO), with regulatory expertise in human nutrition today announced a strategic advisory partnership aimed at accelerating the development and regulatory approval of insect-based solutions for animal health and nutrition.

Elanco Launches Advantage™ Collar for Dogs with Four Months of Continuous Protection from Fleas, Ticks and Mosquitoes*

Elanco Animal Health Incorporated (NYSE: ELAN) today announced the launch of its Advantage™ Collar for Dogs, a new product providing long-lasting protection against two parasites that don't take a season off – fleas and ticks.

Boehringer Ingelheim Introduces LENZELTA®: A New Vaccine Advancing Mastitis Prevention in Dairy Cows

With the launch of LENZELTA®, Boehringer Ingelheim enhances its comprehensive mastitis portfolio, offering farmers and veterinarians effective solutions to keep their dairy cattle healthy and farms viable.

Explore Further

Explore these resources to learn more about the Animal Health Corridor and industry.

Industry Trends & Insights

Stay informed on the market forces and innovations transforming animal health.

Corridor Asset Overview

Take a deep dive into the comprehensive benefits and assets of the KC Animal Health Corridor.